- You are here:
-
Home
-
Methods & Publications
- Pre-published methods
Pre-published methods
CIPAC Methods are available on a per-method basis, as long as they are not yet published in a Handbook. CIPAC charges a nominal fee per method.
Instructions
| ♦ | The list of pre-published methods below is exhaustive. |
| ♦ | Tick the method or methods you wish to receive in the orderform. The methods are sent as pdf files attached to an e-mail - a working e-mail address is therefore mandatory |
| ♦ | Each method is charged with GBP 5. Please sum the number of methods you wish to receive and calculate the grand total. Print the form duly filled and signed, to Marston Book Services (see details below) by fax. |
| ♦ | As soon as you order is processed, you shall receive the pdf files by e-mail attachment. |
Terms of Use
By ordering one or more of these methods, the user accepts the conditions of use as follows:
| ♦ | These are draft methods and are subject to revision without further notice |
| ♦ | These methods will appear in revised and edited form in CIPAC Handbook P presumably in the year 2020. The pre-published methods expire as soon as they appear in printed form in the CIPAC Handbook P. |
| ♦ | The CIPAC copyright and disclaimer (cf. CIPAC Handbook L, page ii) applies to all pre-published methods. |
List of available methods
|
Number
|
Name
|
Description |
Status
|
| 635 | Silthiofam | The reversed phase HPLC method using internal standard (CIPAC/5004) for the determination of silthiofam in TC and FS formulations was accepted as a full CIPAC method with the inclusion of a note that the addition of the internal standard can be done also volumetrically (ISBN 978-1-911009-05-4). | full |
| 715 | Pyriproxyfen | The extension of the scope (CIPAC/4997) of CIPAC method 715/TC/M/3 for the determination of the pyriproxyfen content of a matrix release formulation (MR) (incorporated type) was accepted as full CIPAC method (ISBN 978-1-911009-06-1). | full |
| 794 | Chlorantraniliprole | The reversed phase HPLC method using internal standard (CIPAC/5034) for the determination of chlorantraniliprole in TC, FS, WG and SC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-09-2). | full |
| 693 | Fenazaquin | The reversed phase HPLC method using external standardisation (CIPAC/5036) for the determination of fenazaquin in TC and SC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-10-8). | full |
| 738 | Clothianidin | The extension of the scope (CIPAC/5051) of CIPAC method 738/WG/M/ for the determination of the clothianidin content of WP formulations was accepted as a full CIPAC method (ISBN 978-1-911009-13-9). | full |
| 715 and 454 |
Pyriproxyfen and alpha-cypermethrin |
The existing extension of the scope (CIPAC/4887) of CIPAC method 715/TC/M/2 for the determination of the pyriproxyfen content of a long lasting insecticidal mosquito net (incorporated type) (LN) containing permethrin and pyriproxyfen is applicable for the long lasting insecticidal mosquito net containing pyriproxyfen and alphacypermethrin (Royal Guard) (CIPAC/5054). The extension of the scope (CIPAC/5054) of CIPAC method 454/LN/M/3.2 for the determination of the alphacypermethrin content of the long lasting insecticidal mosquito net (incorporated type) (LN) containing alphacypermethrin and pyriproxyfen, with the modification of having di-cyclohexyl phthalate as internal standard, instead of dioctyl phthalate, was accepted as a full CIPAC method |
full |
| 221.202 | Chlorpyrifos ethyl |
The reversed phase HPLC method using internal standard (CIPAC/5080) for the determination of chlorpyrifos ethyl in long lasting insecticidal nets was accepted as full CIPAC method (ISBN 978-1-911009-20-7). | full |
| 804 | d.d-trans- Cyphenothrin |
The extension of the scope (CIPAC/5082) of CIPAC method 804/EC/(M)/ for the determination of the d,d-trans-cyphenothrin content in Metofluthrin/d,d-trans-Cyphenothrin/Piperonyl butoxide EW formulations was accepted as full CIPAC method (ISBN 978-1-911009-21-4). | full |
| 33 | Piperonyl butoxide |
The extension of the scope (CIPAC/5084) of CIPAC method 33/EW/M/3 for the determination of the piperonyl butoxide content in Metofluthrin/d,d-trans-Cyphenothrin/Piperonyl butoxide EW formulations, with the use of triphenyl phosphate as internal standard, was accepted as fullCIPAC method (ISBN 978-1-911009-22-1). |
full |
| 987 | Flupyradifurone | The reversed phase HPLC method (CIPAC/5094) for the determination of flupyradifurone in TC, AL, EC, EW, FS, SL and WG formulations was accepted as full CIPAC method with the need to insert a comment concerning the sample preparation for the WG formulation (ISBN 978-1-911009-23-8). | full |
| 989 | d-Tetramethrin | The capillary GC method (CIPAC/5101) using internal standard for the determination of d-tetramethrin in TC formulations and the chiral phase HPLC method (CIPAC/5101) for the determination of the isomer ratio of d-tetramethrin in TC formulations were accepted as full CIPAC methods (ISBN 978-1-911009-24-5). | full |
| 749 | Dinetofuran | The extension of the scope (CIPAC/5097) of CIPAC method 749/TC/M/3 for the determination of the dinotefuran content in ready to use bait formulation (sugar solution), with the modification of the eluent profile and sample preparation, was accepted as full CIPAC method (ISBN 978-1-911009-25-2). | full |
| 582 | Imidacloprid | The extension of the scope (CIPAC/5108) of CIPAC method 582/TC/M2/ for the determination of the imidacloprid content in UL formulations, with the modification of the run time, was accepted as full CIPAC method (ISBN 978-1-911009-26-9). |
full |
| 408 | Propiconazole | The capillary GC method using internal standard (CIPAC/5150) for the determination of propiconazole in TC and EC formulations was accepted as a full CIPAC method, with the note that acetone can also be used instead of MIBK (ISBN 978-1-911009-27-6). | full |
| 745 | Prothioconazole | The reversed phase HPLC method (CIPAC/5159) for the determination of prothioconazole in TC, EC, FS and SC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-28-3). | full |
| 733 | zeta-Cypermethrin | The chiral HPLC method (CIPAC/5143) for the determination of the S/R isomer ratio of zeta-cypermethrin in technical active substance was accepted as a stereospecific identity test to be used with the existing CIPAC method 332 (ISBN 978-1-911009-29-0). |
identity test |
| 743 | Prallethrin | The extension of the scope (CIPAC/5163) of CIPAC method 743/LV/M/- for the determination of the prallethrin content in UL formulations, with the modifications in the inlet and detector temperatures and use of standard addition for quantification, was accepted as full CIPAC method (ISBN 978-1-911009-30-6). | full |
| 338 | Acephate | The reversed phase HPLC method using internal standard (CIPAC/5207) for the determination of acephate in TC and SP formulations was accepted as a full CIPAC method, with the note that the method can also be used without the internal standard (ISBN 978-1-911009-34-4). | full |
| 54 and 570 | alpha-Cypermethrin and Chlorfenapyr |
The capillary GC method using internal standard (CIPAC/5220) for the determination of alpha-cypermethrin and chlorfenapyr in LN formulations was accepted as a full CIPAC method (ISBN 978-1-911009-35-1). | full |
| 91 | Atrazine | The capillary GC method using internal standard (CIPAC/5215) for the determination of atrazine in TC, WG and SC formulations was accepted as a full CIPAC method, with the request to remove the data set obtained with the multi-method and inclusion of the HorRat values (ISBN 978-1-911009-36-8). | full |
| 994 | Broflanilide | The reversed phase HPLC method (CIPAC/5213) for the determination of broflanilide in TC and WP formulations was accepted as a full CIPAC method (ISBN 978-1-911009-37-5). | full |
| 997 | Cyetpyrafen | The reversed phase HPLC method (CIPAC/5191) for the determination of etpyrafen in TC and SC formulations was accepted as a full CIPAC method, with the note that the name should be modified to cyetpyrafen (ISBN 978-1-911009-38-2). | fulll |
| 465 | Hexconazole | The reversed phase HPLC method (CIPAC/5209) for the determination of hexaconazole in TC, WG and SC formulations was accepted as a full CIPAC method. The HorRat values should be calculated and reported (ISBN 978-1-911009-39-9). | full |
| 34 | Mancozeb | The reversed phase HPLC method (CIPAC/5157) for the determination of mancozeb in TC and WP formulations was accepted as a full CIPAC method with some precisions in the description of the method (ISBN 978-1-911009-40-5). | full |
| 737 | Spirodiclofen | The reversed phase HPLC method (CIPAC/5195) for the determination of spirodiclofen in TC and SC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-41-2). | full |
| 616 | Florasulam | The reversed phase HPLC method (CIPAC/5257) for the determination of florasulam in TC and SC formulations was accepted as a provisional CIPAC method, with some additional editorial amendments in method description, inclusion of method for the determination of suspensibility for SC formulation (ISBN 978-1-911009-43-6). | provisional |
| 283 | Metribuzin | The capillary gas chromatographic method with split injection, using dipentylphthalate as internal standard and helium as eluent (CIPAC/5253), for the determination of metribuzin in TC, SC, WG and WP formulations was accepted as a provisional CIPAC method. It was proposed to consider the HorRat values resulted from the data sets using helium as eluent gas (ISBN 978-1-911009-44-3). |
provisional |
| 641.202 | Quizalofop-P-ethyl | The chiral phase HPLC method (CIPAC/5255) for the determination of quizalofopP-ethyl in TC and EC formulations was accepted as a provisional CIPAC method,with additional modifications in the description of the method considering the selectivity of the column (using the right eluent) and inclusion of a second selective identity test (ISBN 978-1-911009-45-0). | provisional |
| 802 | Spinetoram | The reversed phase HPLC method (CIPAC/5249) for the determination of spinetoram in TC, SC, WG, and DT formulations was accepted as a provisional CIPAC method pending on the amendments of the description of the method, inclusion of the identity tests, method for the determination of suspensibility for SC formulation, representative chromatograms (ISBN 978-1-911009-46-7). | provisional |
| MT 46.3 |
Accelerated storage procedure |
The extension of the scope (CIPAC/5045) of CIPAC method MT 46.3 for the accelerated storage procedure of the MR formulations regarding determination of active ingredient content and retention index was accepted as a full CIPAC MT method (ISBN 978-1-911009-12-2). | full |
| MT 200 |
Retention properties of pyriproxyfen MR formulations |
The method for the determination of retention properties of pyriproxyfen matrix release formulations (CIPAC/4999) was accepted as a full CIPAC MT method with the request of additional validation data (ISBN 978-1-911009-07-8). | full |
| MT 30.6 | Water determination by Karl Fischer method |
The revision of the MT 30.5, Karl Fischer method using pyridine-free reagents (CIPAC/5154) was accepted as full CIPAC method (ISBN 978-1-911009-31-3). | full |
| MT 172.2 |
Flowability of Granular Formulations after Accelerated Storage under Pressure |
The revision of the CIPAC MT 172.1, Flowability of Granular Formulations (CIPAC/5155) was accepted as full CIPAC method (ISBN 978-1-911009-32-0). | fulll |
| MT 184.1 | Suspensibility of Formulations forming Suspensions on Dilution with Water |
The revision of the CIPAC MT 184, Suspensibility of formulations forming suspensions on dilution with water (CIPAC/5156) was accepted as full CIPAC method (ISBN 978-1-911009-33-7). | full |
| MT 46.4 | Accelerated Storage Procedure |
The harmonized accelerated storage procedure for all formulation types (CIPAC/5217) was accepted as a full CIPAC method. MT 46.4 supersedes all previous versions of MT 46 for accelerated storage (ISBN 978-1-911009-42-9). | full |
| MT 190.1 | Determination of Release Properties of lambda- Cyhalothrin CS Formulations |
The revision of the CIPAC MT 190, Determination of Release Properties of lambda-Cyhalothrin CS Formulations (CIPAC/5260) was accepted as full CIPAC method (ISBN 978-1-911009-47-4). | full |
